|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0027819,
umls-concept:C0030705,
umls-concept:C0033204,
umls-concept:C0038952,
umls-concept:C0205216,
umls-concept:C0242656,
umls-concept:C0524869,
umls-concept:C0681842,
umls-concept:C1516476,
umls-concept:C1520972,
umls-concept:C2603343
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
2000-6-8
|
|
pubmed:abstractText |
To determine the independent prognostic significance of 1p36 loss of heterozygosity (LOH) in a representative group of neuroblastoma patients.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
pubmed-author:BrodeurG MGM,
pubmed-author:GerbingR BRB,
pubmed-author:GutDD,
pubmed-author:HogartyM DMD,
pubmed-author:LukensJ NJN,
pubmed-author:MalanP JPJ,
pubmed-author:MatthayK KKK,
pubmed-author:SeegerR CRC,
pubmed-author:StramD ODO,
pubmed-author:SulmanE PEP,
pubmed-author:ThompsonP MPM,
pubmed-author:WeissM JMJ,
pubmed-author:WhiteP SPS
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
18
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1888-99
|
|
pubmed:dateRevised |
2007-11-14
|
|
pubmed:meshHeading |
pubmed-meshheading:10784629-Child,
pubmed-meshheading:10784629-Child, Preschool,
pubmed-meshheading:10784629-Disease Progression,
pubmed-meshheading:10784629-Disease-Free Survival,
pubmed-meshheading:10784629-Female,
pubmed-meshheading:10784629-Gene Amplification,
pubmed-meshheading:10784629-Genes, myc,
pubmed-meshheading:10784629-Humans,
pubmed-meshheading:10784629-Infant,
pubmed-meshheading:10784629-Loss of Heterozygosity,
pubmed-meshheading:10784629-Male,
pubmed-meshheading:10784629-Microsatellite Repeats,
pubmed-meshheading:10784629-Neuroblastoma,
pubmed-meshheading:10784629-Predictive Value of Tests,
pubmed-meshheading:10784629-Prognosis,
pubmed-meshheading:10784629-Prospective Studies,
pubmed-meshheading:10784629-Risk Factors
|
|
pubmed:year |
2000
|
|
pubmed:articleTitle |
Loss of heterozygosity at 1p36 independently predicts for disease progression but not decreased overall survival probability in neuroblastoma patients: a Children's Cancer Group study.
|
|
pubmed:affiliation |
Department of Pediatrics, University of Pennsylvania School of Medicine and Children's Hospital of Philadelphia, Philadelphia, PA, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
